These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33335741)
1. Technique Survival and Determinants of Technique Failure in In-Center Nocturnal Hemodialysis: A Retrospective Observational Study. Schachter ME; Saunders MJ; Akbari A; Caryk JM; Bugeja A; Clark EG; Tennankore KK; Martinusen DJ Can J Kidney Health Dis; 2020; 7():2054358120975305. PubMed ID: 33335741 [TBL] [Abstract][Full Text] [Related]
2. Long-Term In-Center Nocturnal Hemodialysis Improves Renal Anemia and Malnutrition and Life Quality of Older Patients with Chronic Renal Failure. Gong Y; Xie L; Yu S Clin Interv Aging; 2022; 17():915-923. PubMed ID: 35686029 [TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Lacson E; Wang W; Lester K; Ofsthun N; Lazarus JM; Hakim RM Clin J Am Soc Nephrol; 2010 Feb; 5(2):220-6. PubMed ID: 19965529 [TBL] [Abstract][Full Text] [Related]
4. Association between patient psychosocial characteristics and receipt of in-center nocturnal hemodialysis among prevalent dialysis patients. Wilk AS; Tang Z; Hoge C; Plantinga LC; Lea JP Hemodial Int; 2019 Oct; 23(4):479-485. PubMed ID: 31579998 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the clinical experience of a regional in-center nocturnal hemodialysis program: The patient and staff perspective. Hull KL; Quann N; Glover S; Wimbury C; Churchward DR; Pickering WP; Preston R; Baines R; Graham-Brown MPM; Burton JO Hemodial Int; 2021 Oct; 25(4):447-456. PubMed ID: 34133061 [TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. Wald R; Yan AT; Perl J; Jiang D; Donnelly MS; Leong-Poi H; McFarlane PA; Weinstein JJ; Goldstein MB BMC Nephrol; 2012 Jan; 13():3. PubMed ID: 22260388 [TBL] [Abstract][Full Text] [Related]
7. Technique Failure in a Multicenter Canadian Home Hemodialysis Cohort. Pauly RP; Rosychuk RJ; Usman I; Reintjes F; Muneer M; Chan CT; Copland M; Lindsay R; MacRae J; Nesrallah G; Pierratos A; Zimmerman DL; Komenda P Am J Kidney Dis; 2019 Feb; 73(2):230-239. PubMed ID: 30392981 [TBL] [Abstract][Full Text] [Related]
8. In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Bugeja A; Dacouris N; Thomas A; Marticorena R; McFarlane P; Donnelly S; Goldstein M Clin J Am Soc Nephrol; 2009 Apr; 4(4):778-83. PubMed ID: 19339410 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis. Bugeja A; Harris S; McCormick B; Brown PA; Liberty C; Krepelka T; St-Cyr G; Akbari A Am J Nephrol; 2019; 50(4):255-261. PubMed ID: 31434091 [TBL] [Abstract][Full Text] [Related]
10. The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. Wald R; Goldstein MB; Perl J; Kiaii M; Yuen D; Wald RM; Harel Z; Weinstein JJ; Jakubovic B; Leong-Poi H; Kirpalani A; Leipsic J; Dacouris N; Wolf M; Yan AT Can J Cardiol; 2016 Mar; 32(3):369-77. PubMed ID: 26386732 [TBL] [Abstract][Full Text] [Related]
11. Nutritional status after conversion from conventional to in-centre nocturnal hemodialysis. Noori N; Yan AT; Kiaii M; Rathe A; Goldstein MB; Bello O; Wald R Int Urol Nephrol; 2017 Aug; 49(8):1453-1461. PubMed ID: 28456922 [TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
14. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Alfaadhel TA; Soroka SD; Kiberd BA; Landry D; Moorhouse P; Tennankore KK Clin J Am Soc Nephrol; 2015 May; 10(5):832-40. PubMed ID: 25739851 [TBL] [Abstract][Full Text] [Related]
15. The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial. Hull KL; Bramham K; Brookes CL; Cluley V; Conefrey C; Cooper NJ; Eborall H; Fotheringham J; Graham-Brown MPM; Gray LJ; Mark PB; Mitra S; Murphy GJ; Quann N; Rooshenas L; Warren M; Burton JO Trials; 2023 Aug; 24(1):522. PubMed ID: 37573352 [TBL] [Abstract][Full Text] [Related]
17. In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease. Dumaine CS; Ravani P; Parmar MK; Leung KCW; MacRae JM J Nephrol; 2022 Jan; 35(1):245-253. PubMed ID: 34050903 [TBL] [Abstract][Full Text] [Related]
18. Risk of hospitalization, technique failure, and death with increased training duration in 3-days-a-week home hemodialysis. Morin C; Gionest I; Laurin LP; Goupil R; Nadeau-Fredette AC Hemodial Int; 2021 Oct; 25(4):457-464. PubMed ID: 34169633 [TBL] [Abstract][Full Text] [Related]
20. Impact of frailty on mortality and transfer to hemodialysis after peritoneal dialysis initiation. Gaube S; Clark D; Cooper D; Nadeau-Fredette AC; Vinson A; Tennankore K Perit Dial Int; 2024 Sep; ():8968608241274095. PubMed ID: 39233634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]